Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide

Cancer Gene Therapy

Volumn 8, Issue 3, 2001, Pages 220-230

  Karle, Peter ^a   Renner, Matthias ^a,b   Salmons, Brian ^b   Günzburg, Walter H ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b Bavarian Nordic GmbH   (Germany)

Author keywords

Apoptosis; Bystander effect; Cytochrome P450 2B1; Ifosfamide; Necrosis; Suicide gene

Indexed keywords

CYTOCHROME P450 2B1; CYTOCHROME P450 ISOENZYME; IFOSFAMIDE; PHOSPHORAMIDE MUSTARD; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA CROSS LINKING; DNA DAMAGE; GENE THERAPY; HUMAN; HUMAN CELL; KIDNEY CELL; LYMPHOMA CELL LINE; NONHUMAN; PANCREAS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUICIDE GENE;

ANIMALIA; FELIDAE;

EID: 0035049257     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700290     Document Type: Article

References (36)

1. Role of cytochrome P450 in oxazaphosphorine metabolism
2. Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: Development of a combined chemotherapy/cancer gene therapy strategy
3. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome p450 gene
4. Targeted chemotherapy by intratumor injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450
5. Development, characterization, and virus susceptibility of a feline (Felis catus) renal cell line (CRFK)
6. A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates
7. Establishment and characterization of BALB/c lymphoma lines with B-cell properties
8. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas
9. Apoptosis or necrosis for tumor immunotherapy: What's in a name?
10. Identification of necrotic cell death by the TUNEL assay in the hypoxic-ischemic neonatal rat brain
11. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note
12. False-positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate
13. Apoptotic cells in the human endometrium and placental villi: Pitfalls in applying the TUNEL method
14. Rapid and sensitive detection of enhanced green fluorescent protein expression in paraffin sections by confocal laser scanning microscopy
15. Three-color immunofluorescence analysis of mouse B-lymphocyte subpopulations
16. The protein kinase inhibitor staurosporine, like phorbol esters, induces the association of protein kinase C with membranes
17. Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intraarterially in patients with advanced-stage pancreatic carcinoma: A phase I/II study
18. Experimental tumor therapy in mice using the cyclophosphamide activating cytochrome P450 2B1 gene
19. Gene therapy for malignant gliomas using replication incompetent retroviral and adenoviral vectors encoding the cytochrome P450 2B1 gene together with cyclophosphamide
20. The choice of prodrugs for gene directed enzyme prodrug therapy of cancer
21. Mechanism of "bystander effect" killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment
22. Diffusible cytotoxic metabolites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome P450 2B1 cancer gene therapy paradigm
23. In situ delivery of suicide genes for cancer treatment
24. The role of the bystander effect in suicide gene therapy
25. The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT)
26. Metabolic suicide genes in gene therapy
27. Tolerance, danger, and the extended family
28. Apoptosis in tumorigenesis and cancer therapy
29. Induction of apoptosis in murine tumors by cyclophosphamide
30. Cell-cycle disruptions and apoptosis induced by the cyclophosphamide derivative mafosfamide
31. Cytomorphology of murine B16 melanoma in vivo after treatment with cyclophosphamide: Evidence of "oncotic" cell death
32. Studies on micronuclei time response and on the effects of multiple treatments of mutagens on induction of micronuclei
33. DNA adducts from chemotherapeutic agents
34. Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites
35. Cell death: The significance of apoptosis
36. Apoptosis: The physiologic pathway of cell death